These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8649566)

  • 1. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis.
    Moore BD; Slopis JM; Schomer D; Jackson EF; Levy BM
    Neurology; 1996 Jun; 46(6):1660-8. PubMed ID: 8649566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining the frontal subcortical brain vulnerability hypothesis in children with neurofibromatosis type 1: Are T2-weighted hyperintensities related to executive dysfunction?
    Roy A; Barbarot S; Charbonnier V; Gayet-Delacroix M; Stalder JF; Roulin JL; Le Gall D
    Neuropsychology; 2015 May; 29(3):473-84. PubMed ID: 25365565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological profile in Italian children with neurofibromatosis type 1 (NF1) and their relationships with neuroradiological data: Preliminary results.
    Parmeggiani A; Boiani F; Capponi S; Duca M; Angotti M; Pignataro V; Sacrato L; Spinardi L; Vara G; Maltoni L; Cecconi I; Pastore Trossello M; Franzoni E
    Eur J Paediatr Neurol; 2018 Sep; 22(5):822-830. PubMed ID: 29802023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of planum temporale and planum parietale morphologic features in neurofibromatosis type 1.
    Billingsley RL; Schrimsher GW; Jackson EF; Slopis JM; Moore BD
    Arch Neurol; 2002 Apr; 59(4):616-22. PubMed ID: 11939897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific learning disability in children with neurofibromatosis type 1: significance of MRI abnormalities.
    North K; Joy P; Yuille D; Cocks N; Mobbs E; Hutchins P; McHugh K; de Silva M
    Neurology; 1994 May; 44(5):878-83. PubMed ID: 8190291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T2 hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning.
    Hyman SL; Gill DS; Shores EA; Steinberg A; North KN
    J Neurol Neurosurg Psychiatry; 2007 Oct; 78(10):1088-91. PubMed ID: 17299016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural history of cognitive deficits and their relationship to MRI T2-hyperintensities in NF1.
    Hyman SL; Gill DS; Shores EA; Steinberg A; Joy P; Gibikote SV; North KN
    Neurology; 2003 Apr; 60(7):1139-45. PubMed ID: 12682321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1997 IPA/Bayer Research Awards in Psychogeriatrics. Subcortical hyperintensities in late-life depression: acute response to treatment and neuropsychological impairment.
    Simpson SW; Jackson A; Baldwin RC; Burns A
    Int Psychogeriatr; 1997 Sep; 9(3):257-75. PubMed ID: 9513027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain morphometry, T2-weighted hyperintensities, and IQ in children with neurofibromatosis type 1.
    Greenwood RS; Tupler LA; Whitt JK; Buu A; Dombeck CB; Harp AG; Payne ME; Eastwood JD; Krishnan KR; MacFall JR
    Arch Neurol; 2005 Dec; 62(12):1904-8. PubMed ID: 16344348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MRI and nonverbal cognitive deficits in children with neurofibromatosis 1.
    Bawden H; Dooley J; Buckley D; Camfield P; Gordon K; Riding M; Llewellyn G
    J Clin Exp Neuropsychol; 1996 Dec; 18(6):784-92. PubMed ID: 9157104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of MRI T2 hyperintensities and cognitive functioning in patients with neurofibromatosis type 1.
    Feldmann R; Schuierer G; Wessel A; Neveling N; Weglage J
    Acta Paediatr; 2010 Nov; 99(11):1657-60. PubMed ID: 21039823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are morphological and structural MRI characteristics related to specific cognitive impairments in neurofibromatosis type 1 (NF1) children?
    Baudou E; Nemmi F; Biotteau M; Maziero S; Assaiante C; Cignetti F; Vaugoyeau M; Audic F; Peran P; Chaix Y
    Eur J Paediatr Neurol; 2020 Sep; 28():89-100. PubMed ID: 32893091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities.
    Feldmann R; Denecke J; Grenzebach M; Schuierer G; Weglage J
    Neurology; 2003 Dec; 61(12):1725-8. PubMed ID: 14694037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropsychological function and MRI abnormalities in neurofibromatosis type 1.
    Joy P; Roberts C; North K; de Silva M
    Dev Med Child Neurol; 1995 Oct; 37(10):906-14. PubMed ID: 7493724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain tumors in children with neurofibromatosis: additional neuropsychological morbidity?
    De Winter AE; Moore BD; Slopis JM; Ater JL; Copeland DR
    Neuro Oncol; 1999 Oct; 1(4):275-81. PubMed ID: 11550319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain morphometric analysis in neurofibromatosis 1.
    DiMario FJ; Ramsby GR; Burleson JA
    Arch Neurol; 1999 Nov; 56(11):1343-6. PubMed ID: 10555653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning.
    Piscitelli O; Digilio MC; Capolino R; Longo D; Di Ciommo V
    Dev Med Child Neurol; 2012 Jan; 54(1):49-51. PubMed ID: 22107256
    [No Abstract]   [Full Text] [Related]  

  • 18. T2-weighted hyperintensities (unidentified bright objects) in children with neurofibromatosis 1: their impact on cognitive function.
    Goh WH; Khong PL; Leung CS; Wong VC
    J Child Neurol; 2004 Nov; 19(11):853-8. PubMed ID: 15658789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group.
    Descheemaeker MJ; Plasschaert E; Frijns JP; Legius E
    J Intellect Disabil Res; 2013 Sep; 57(9):874-86. PubMed ID: 23095048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Learning disabilities in neurofibromatosis 1: sizing up the brain.
    Gutmann DH
    Arch Neurol; 1999 Nov; 56(11):1322-3. PubMed ID: 10555648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.